FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/081544 [Registered on: 03/03/2025] Trial Registered Prospectively
Last Modified On: 20/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Ayurvedic management of vatika sirahsula(migraine) 
Scientific Title of Study   comparative study of Sirahsuladrivjra rasa along with Pathyadi kvatha and nimbadi guggulu along with dashmula kvatha in vatika sirahsula w.s.r to (migraine) 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mansi Goklani 
Designation  PG Scholar 
Affiliation  J S Ayurveda Mahavidhyalaya  
Address  PG Department of kayachikitsa js ayurveda mahavidhyalaya college road nadiad

Kheda
GUJARAT
387001
India 
Phone  9157283700  
Fax    
Email  thakkarmansi784@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Dhaval Dholakiya 
Designation  professor 
Affiliation  J S Ayurved Mahavidyalaya 
Address  PG Department of kayachikitsa js ayurveda mahavidhyalaya college road nadiad kheda gujarat 387001 india

Kheda
GUJARAT
387001
India 
Phone  7016786089  
Fax    
Email  vddhavaldholakiya1910@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Dhaval Dholakiya 
Designation  professor 
Affiliation  J S Ayurved Mahavidyalaya 
Address  PG Department of kayachikitsa js ayurveda mahavidhyalaya college road nadiad kheda gujarat 387001 india

Kheda
GUJARAT
387001
India 
Phone  7016786089  
Fax    
Email  vddhavaldholakiya1910@gmail.com  
 
Source of Monetary or Material Support  
Sundar Ayurved Teaching pharmacy with J S Ayurveda Mahavidyalaya nadiad kheda gujarat 387001 india 
 
Primary Sponsor  
Name  J S Ayurveda Mahavidhyalaya  
Address  college road nadiad kheda gujarat 387001 india 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mansi Goklani  P D patel ayurveda hospital  PG Department of kayachikitsa js ayurveda mahavidhyalaya college road nadiad kheda gujarat 387001 india
Kheda
GUJARAT 
9157283700

thakkarmansi784@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institics commitee for human research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:G439||Migraine, unspecified. Ayurveda Condition: SIROROGAH/SIRAHSULA/SIRASTAPA/SIROBITAPA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: nimbadi guggulu, Reference: Dattram Sh. Krishanlal Mathur, Brihat Nighantu Ratnakar Part 6, Khemraja Shri Krishandas Prakashan, Mumbai, 1981, P-398, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 300(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 6 Weeks, anupAna/sahapAna: Yes(details: ushnodaka), Additional Information: -
(2) Medicine Name: Dasamula kvatha, Reference: Sarangdhara Samhita, MadhyamaKhanda 2 Verse 28-31, 1st Edition. Edited by Dr. G. Prabhakar Rao. Varanasi: Chaukhamba Publications, 2013., Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: sirahsuladri vajra rasa, Reference: Bhaisajya ratnavali, Sirorogadhikara, 140-144, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 6 Weeks, anupAna/sahapAna: Yes(details: ushnodaka), Additional Information: -
(2) Medicine Name: pathyadi kvath, Reference: Sarangadhara Samhita, MadhyamaKhanda 2 Verse 143-145, 1st Edition. Edited by Dr. G. Prabhakar Rao. Varanasi: Chaukhamba Publications, 2013., Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 10(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 6 Weeks, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients with classically defined Migraine.
Migraine headache (without aura)- At least five attacks fulfilling criteria B through D from diagnostic criteria of migraine without aura.
Migraine headache (with aura) - At least five attacks fulfilling criteria B through D from diagnostic criteria of migraine with aura.
 
 
ExclusionCriteria 
Details  Patients on corticosteroids, who received psycho pharmacological agents in last 6 months.
Pregnant and lactating women.
Patient having any other clinical condition i.e. Diabetes mellitus, Hyperthyroidism, Hypothyroidism, Cardiovascular disease, Tuberculosis and Parkinson’s disease.
Patient having any abnormal MRI which suggest critical conditions like SOL or patient having clinical condition of nausea/vomiting with seizures or acute psychological disturbances which clinically indicate SOL.
Patients suffering from Sinusitis, Hypertension, and Fever, Secondary headache caused by Meningitis, Tumor, Encephalitis, Cervical Spondylitis and Refractive errors.
patients using any other systemic drugs which may alter the results of the study were excluded.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
changes in signs and symptoms in the patients of vatika sirahsula (migraine)  • Patient will be treated at O. P. D. level for 6 weeks of treatment schedule. They will come for follow-up after every 2 weeks. 
 
Secondary Outcome  
Outcome  TimePoints 
changes in signs and symptoms in the patients of vatika sirahsula (migraine)  • Patient will be treated at O. P. D. level for 6 weeks of treatment schedule. They will come for follow-up after every 2 weeks. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Migraines cause a lot of physical, emotional and social challenges, greatly affecting your overall well-being. The usual drugs for treating migraines include regular painkillers like NSAIDs, opioids, barbiturates, combination analgesics and antiemetics, as well as migraine-specific medications such as triptans, ergot alkaloids and their derivatives. However, these treatments offer only temporary relief and have multiple side effects.

 Sirahsuladri vajra rasa and pathyadi kvatha are being used by many Ayurveda physician in routine   practice with satisfactory results. Sirahsuladri vajra rasa is mentioned in bhesjyaratnavalli  ,  pathyadi kvatha & dasamula kvatha in sarangadhar samhita whereas nimbadi guggulu  in brhat nighant­u ratnakara for the treatment of siroroga .Hence, nimbadi guggulu and dasamula kvatha may be effective in Vatika sirahsula .Till date no any comparative research work found on the above therapy for the management of vatika sirahsula (migraine).

 
Close